What is CFH?
Founded in 2014, CFH, Ltd. operates as a vertically integrated hemp bioscience enterprise, distinguishing itself through the production of high-quality, full-spectrum CBD products. By leveraging proprietary hemp strains, the company ensures that its offerings maintain the natural equilibrium of cannabinoids, terpenes, and flavonoids found in the raw plant material. This focus on botanical integrity and efficacy has positioned CFH as a leading supplier in the nationwide CBD market, catering to a growing consumer base that prioritizes transparency and scientific rigor in wellness products. The company's operational model spans the entire value chain, from cultivation to final product distribution, allowing for stringent quality control and consistent product performance.
How much funding has CFH raised?
CFH has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in CFH
PPP
Public-Private Partnership
What's next for CFH?
With the recent influx of capital, CFH is well-positioned to accelerate its strategic initiatives, particularly in the realms of product innovation and market penetration. The company is expected to leverage these resources to deepen its research into the therapeutic potential of minor cannabinoids and to optimize its proprietary extraction processes. As the regulatory environment for hemp-derived products continues to evolve, CFH's focus on maintaining a high-efficacy, full-spectrum profile will likely serve as a competitive moat. Future growth trajectories will likely involve scaling production capacity to meet rising demand while simultaneously investing in clinical validation to further solidify its reputation as a science-led leader in the hemp bioscience industry. Keywords: hemp bioscience, CBD supply chain, cannabinoid research, full-spectrum CBD, botanical extraction, hemp industry growth, strategic capital investment.
See full CFH company page
